AMERICAN ASSOCIATION FOR HOMECARE

Lobbying for AMERICAN ASSOCIATION FOR HOMECARE

Filing 3rd Quarter - Report

Reporting period

3rd Quarter 2025

July 1 - Sep 30 · Posted Oct 15, 2025

Expenses

$300,000.00

What this organization spent lobbying with its own staff. Reported using A: the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

Virginia

Official filing document

Government bodies contacted 7

Centers For Medicare and Medicaid Services (CMS)
Food & Drug Administration (FDA)
Government Accountability Office (GAO)
Health & Human Services, Dept of (HHS)
HOUSE OF REPRESENTATIVES
Office of Management & Budget (OMB)
SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Bills named in this filing 4

HR 2005
DMEPOS Relief Act of 2025
S 2951
Competitive Bidding Relief Act
HR 1703
Choices for Increased Mobility Act of 2026
S 247
Choices for Increased Mobility Act of 2025

Lobbying activity 2

Medicare/Medicaid

Issues pertaining to durable medical equipment including competitive bidding, power wheelchairs, oxygen, non-invasive ventilators, diabetic supplies, negative pressure wound therapy, Medicare audits, and sequestration; Issues related to Medicare sequestration paygo relief legislation; Issues related to Medicare titanium/carbon upgrade legislation, and Medicare coverage of seat elevation and standing features; H.R. 2005- DMEPOS Relief Act of 2025 (issues related to Medicare reimbursement cuts in DME noncompetitive bidding areas); S. 2951 - A bill to direct the Secretary of Health and Human Services to provide for certain adjustments to Medicare payment for items of durable medical equipment that were formerly included in round 2021 of the DMEPOS competitive bidding program (issues related to Medicare reimbursement cuts in DME noncompetitive bidding areas); H.R. 1703/S. 247 - Choices for Increased Mobility Act of 2025.

Tariff (miscellaneous tariff bills)

Issues related to tariffs on medical devices.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.